| Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients P Steinacker, E Feneberg, J Weishaupt, J Brettschneider, H Tumani, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (1), 12-20, 2016 | 323 | 2016 |
| Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis F Verde, P Steinacker, JH Weishaupt, J Kassubek, P Oeckl, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (2), 157-164, 2019 | 205 | 2019 |
| Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis E Feneberg, P Oeckl, P Steinacker, F Verde, C Barro, P Van Damme, ... Neurology 90 (1), e22-e30, 2018 | 189 | 2018 |
| Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases E Feneberg, P Steinacker, S Lehnert, A Schneider, P Walther, DR Thal, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15 (5-6), 351-356, 2014 | 158 | 2014 |
| Towards a TDP-43-based biomarker for ALS and FTLD E Feneberg, E Gray, O Ansorge, K Talbot, MR Turner Molecular neurobiology 55, 7789-7801, 2018 | 140 | 2018 |
| Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity … P Steinacker, F Verde, L Fang, E Feneberg, P Oeckl, S Roeber, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (3), 239-247, 2018 | 118 | 2018 |
| Poly‐GP in cerebrospinal fluid links C9orf72‐associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD C Lehmer, P Oeckl, JH Weishaupt, AE Volk, J Diehl‐Schmid, ... EMBO Molecular Medicine 9 (7), 859-868, 2017 | 118 | 2017 |
| Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias P Steinacker, E Semler, S Anderl-Straub, J Diehl-Schmid, ML Schroeter, ... Neurology 88 (10), 961-969, 2017 | 89 | 2017 |
| Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS S Halbgebauer, P Steinacker, F Verde, J Weishaupt, P Oeckl, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (1), 68-74, 2022 | 58 | 2022 |
| Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update P Oeckl, P Steinacker, E Feneberg, M Otto Journal of neurochemistry 138, 184-192, 2016 | 45 | 2016 |
| Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain AG Thompson, E Gray, N Verber, Y Bobeva, V Lombardi, SR Shepheard, ... Brain communications 4 (1), fcac029, 2022 | 44 | 2022 |
| Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer’s disease and frontotemporal lobar degeneration P Oeckl, P Steinacker, CAF von Arnim, S Straub, M Nagl, E Feneberg, ... Journal of proteome research 13 (11), 4518-4525, 2014 | 44 | 2014 |
| Amyotrophic lateral sclerosis: the complex path to precision medicine K Talbot, E Feneberg, J Scaber, AG Thompson, MR Turner Journal of neurology 265, 2454-2462, 2018 | 42 | 2018 |
| Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD E Feneberg, P Steinacker, AE Volk, JH Weishaupt, MA Wollmer, A Boxer, ... Journal of Neural Transmission 123, 289-296, 2016 | 37 | 2016 |
| Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: current status and future perspectives P Oeckl, P Steinacker, E Feneberg, M Otto Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1854 (7), 757-768, 2015 | 35 | 2015 |
| Detection and quantification of novel C‐terminal TDP‐43 fragments in ALS‐TDP E Feneberg, PD Charles, MJ Finelli, C Scott, BM Kessler, R Fischer, ... Brain Pathology 31 (4), e12923, 2021 | 33 | 2021 |
| SARS-CoV-2 and neurodegenerative diseases: What we know and what we don’t P Lingor, AF Demleitner, AW Wolff, E Feneberg Journal of Neural Transmission 129 (9), 1155-1167, 2022 | 26 | 2022 |
| An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress E Feneberg, D Gordon, AG Thompson, MJ Finelli, R Dafinca, A Candalija, ... Neurobiology of disease 144, 105050, 2020 | 25 | 2020 |
| Initial identification of a blood-based chromosome conformation signature for aiding in the diagnosis of amyotrophic lateral sclerosis M Salter, E Corfield, A Ramadass, F Grand, J Green, J Westra, CR Lim, ... EBioMedicine 33, 169-184, 2018 | 22 | 2018 |
| Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study P Steinacker, E Feneberg, S Halbgebauer, S Witzel, F Verde, P Oeckl, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22 (3-4), 276-286, 2021 | 17 | 2021 |
